{"id":"https://openalex.org/A5066670477","orcid":"https://orcid.org/0000-0002-8413-4406","observed_orcids":["https://orcid.org/0000-0002-8413-4406"],"display_name":"Yeejin Jeon","raw_author_names":["Yeejin Jeon"],"full_name":"Yeejin Jeon","works_count":19,"cited_by_count":113,"summary_stats":{"2yr_mean_citedness":4.25,"h_index":4,"i10_index":4},"ids":{"openalex":"https://openalex.org/A5066670477","orcid":"https://orcid.org/0000-0002-8413-4406","observed_orcids":["https://orcid.org/0000-0002-8413-4406"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210158309","ror":"https://ror.org/058kbr222","display_name":"Qurient (South Korea)","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210158309"]},"years":[2026,2024,2023,2022,2021,2020,2019,2018]}],"last_known_institutions":[{"id":"https://openalex.org/I4210158309","ror":"https://ror.org/058kbr222","display_name":"Qurient (South Korea)","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210158309"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":5,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","count":5,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","count":3,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","value":6.3e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","value":5.52e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","value":4.28e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","value":3.77e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","value":3.49e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.7519913911819458},{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.7029476165771484},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.6472241878509521},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.5747318267822266},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.5042980909347534}],"counts_by_year":[{"year":2018,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2019,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2020,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2021,"works_count":3,"oa_works_count":1,"cited_by_count":0},{"year":2022,"works_count":4,"oa_works_count":2,"cited_by_count":7},{"year":2023,"works_count":3,"oa_works_count":0,"cited_by_count":30},{"year":2024,"works_count":3,"oa_works_count":1,"cited_by_count":22},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":38},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":16}],"display_name_alternatives":["Yeejin Jeon"],"block_key":"y jeon","works_api_url":"https://api.openalex.org/works?filter=author.id:A5066670477","updated_date":"2026-11-04T11:47:51","created_date":"2018-02-23T00:00:00"}
